Cloning and functional characterization of the murine caspase-3 gene promoter

DNA and Cell Biology

Volumn 25, Issue 2, 2006, Pages 104-115

  Sabbagh, Laurent ^a,c   Bourbonnière, Martin ^a,b   Denis, François ^d   Sékaly, Rafick Pierre ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; LUCIFERASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; DNA FLANKING REGION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL; MOLECULAR CLOCK; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SEQUENCE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CASPASE 3; CASPASES; CELL LINE, TUMOR; CLONING, MOLECULAR; GENES, REPORTER; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS);

ANIMALIA; MURINAE;

EID: 33144457625     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.104     Document Type: Article

References (69)

1. ALAM, A., COHEN, L.Y., AOUAD, S., and SEKALY, R.P. (1999). Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190, 1879-1890.
2. ALONSO, M.E., BELLO, M.J., GONZALEZ-GOMEZ, P., ARJONA, D., DE CAMPOS, J.M., GUTIERREZ, M., and REY, J.A. (2004). Aberrant CpG island methylation of multiple genes in ependymal tumors. J. Neurooncol. 67, 159-165.
3. BALDWIN, A.S., JR. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
4. BANELLI, B., CASCIANO, I., CROCE, M., VINCI, A.D., GELVI, I., PAGNAN, G., BRIGNOLE, C., ALLEMANNI, G., FERRINI, S., PONZONI, M., et al. (2002). Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region. Nat. Med. 8, 1333-1335.
5. BELLO, M.J., AMINOSO, C., LOPEZ-MARIN, I., ARJONA, D., GONZALEZ-GOMEZ, P., ALONSO, M.E., LOMAS, J., DE CAMPOS, J.M., KUSAK, M.E., VAQUERO, J., et al. (2004). DNA methylation of multiple promoter-associated CpG islands in meningiomas: Relationship with the allelic status at 1p and 22q. Acta Neuropathol. (Berl) 108, 413-421.
6. BOISSONNAS, A., BONDUELLE, O., LUCAS, B., DEBRE, P., AUTRAN, B., and COMBADIERE, B. (2002). Differential requirement of caspases during naive T cell proliferation. Eur. J. Immunol. 32, 3007-3015.
7. BRANDEIS, M., FRANK, D., KESHET, I., SIEGFRIED, Z., MENDELSOHN, M., NEMES, A., TEMPER, V., RAZIN, A., and CEDAR, H. (1994). Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435-438.
8. CHEN, J., NAGAYAMA, T., JIN, K., STETLER, R.A., ZHU, R.L., GRAHAM, S.H., and SIMON, R.P. (1998). Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914-4928.
9. CHEN, M., ONA, V.O., LI, M., FERRANTE, R.J., FINK, K.B., ZHU, S., BIAN, J., GUO, L., FARRELL, L.A., HERSCH, S.M., et al. (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6, 797-801.
10. CHIN, Y.E., KITAGAWA, M., KUIDA, K., FLAVELL, R.A., and FU, X.Y. (1997). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell Biol. 17, 5328-5337.
11. CHUN, H.J., ZHENG, L., AHMAD, M., WANG, J., SPEIRS, C.K., SIEGEL, R.M., DALE, J.K., PUCK, J., DAVIS, J., HALL, C.G., et al. (2002). Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395-399.
12. DAI, C., and KRANTZ, S.B. (1999). Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93, 3309-3316.
13. DELGADO, S., GOMEZ, M., BIRD, A., and ANTEQUERA, F. (1998). Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J. 17, 2426-2435.
14. DENIS, F., RHEAUME, E., AOUAD, S.M., ALAM, A., SEKALY, R.P., and COHEN, L.Y. (1998). The role of caspases in T cell development and the control of immune responses. Cell. Mol. Life Sci. 54, 1005-1019.
15. DEVARAJAN, E., SAHIN, A.A., CHEN, J.S., KRISHNAMURTHY, R.R., AGGARWAL, N., BRUN, A.M., SAPINO, A., ZHANG, F., SHARMA, D., YANG, X.H., et al. (2002). Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21, 8843-8851.
16. DING, H.F., MCGILL, G., ROWAN, S., SCHMALTZ, C., SHIMAMURA, A., and FISHER, D.E. (1998). Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J. Biol. Chem. 273, 28378-28383.
17. DROIN, N., DUBREZ, L., EYMIN, B., RENVOIZE, C, BREARD, J., DIMANCHE-BOITREL, M.T., and SOLARY, E. (1998). Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene 16, 2885-2894.
18. DUAN, H., CHINNAIYAN, A.M., HUDSON, P.L., WING, J.P., HE, W.W., and DIXIT, V.M. (1996). ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271, 1621-1625.
19. EBINGER, M., SENF, L., WACHOWSKI, O., and SCHEURLEN, W. (2004). Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma. Pathol. Oncol. Res. 10, 17-21.
20. FALK, M., USSAT, S., REILING, N., WESCH, D., KABELITZ, D., and ADAM-KLAGES, S. (2004). Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J. Immunol. 173, 5077-5085.
21. FULDA, S., and DEBATIN, K.M. (2002). IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 21, 2295-2308.
22. GARCIA-MANERO, G., DANIEL, J., SMITH, T.L., KORNBLAU, S.M., LEE, M.S., KANTARHAN, H.M., and ISSA, J.P. (2002). DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin. Cancer Res. 8, 2217-2224.
23. GHOSH, S., MAY, M.J., and KOPP, E.B. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
24. HAKEM, R., HAKEM, A., DUNCAN, G.S., HENDERSON, J.T., WOO, M., SOENGAS, M.S., ELIA, A., DE LA POMPA, J.L., KAGI, D., KHOO, W., et al. (1998). Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352.
25. JAMESON, S.C. (2002). Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2, 547-556.
26. JUAN, T.S., MCNIECE, I.K., JENKINS, N.A., GILBERT, D.J., COPELAND, N.G., and FLETCHER, F.A. (1996). Molecular characterization of mouse and rat CPP32 beta gene encoding a cysteine protease resembling interleukin-1 beta converting enzyme and CED-3. Oncogene 13, 749-755.
27. KENNEDY, N.J., KATAOKA, T., TSCHOPP, J., and BUDD, R.C. (1999). Caspase activation is required for T cell proliferation. J. Exp. Med. 190, 1891-1896.
28. KOZAK, M. (1986). Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283-92.
29. KRAJEWSKA, M., WANG, H.G., KRAJEWSKI, S., ZAPATA, J.M., SHABAIK, A., GASCOYNE, R., and REED, J.C. (1997). Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57, 1605-1613.
30. KUIDA, K., ZHENG, T.S., NA, S., KUAN, C., YANG, D., KARASUYAMA, H., RAKIC, P., and FLAVELL, R.A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372.
31. KUIDA, K., HAYDAR, T.F., KUAN, C.Y., GU, Y., TAYA, C., KARASUYAMA, H., SU, M.S., RAKIC, P., and FLAVELL, R.A. (1998). Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325-337.
32. KUMAR, A., COMMANE, M., FLICKINGER, T.W., HORVATH, C.M., and STARK, G.R. (1997). Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278, 1630-1632.
33. KUMAR, S., TOMOOKA, Y., and NODA, M. (1992). Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185, 1155-1161.
34. KUO, C.T., and LEIDEN, J.M. (1999). Transcriptional regulation of T lymphocyte development and function. Annu. Rev. Immunol. 17, 149-187.
35. LI, K., LI, Y., SHELTON, J.M., RICHARDSON, J.A., SPENCER, E., CHEN, Z.J., WANG, X., and WILLIAMS, R.S. (2000a). Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101, 389-399.
36. LI, M., ONA, V.O., GUEGAN, C., CHEN, M., JACKSON-LEWIS, V., ANDREWS, L.J., OLSZEWSKI, A.J., STIEG, P.E., LEE, J.P., PRZEDBORSKI, S., et al. (2000b). Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335-339.
37. LIEDTKE, C., GROGER, N., MANNS, M.P., and TRAUTWEIN, C. (2003). The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278, 27593-27604.
38. LIPPKE, J.A., GU, Y., SARNECKI, C., CARON, P.R., and SU, M.S. (1996). Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271, 1825-1828.
39. LIU, W., WANG, G., and YAKOVLEV, A.G. (2002). Identification and functional analysis of the rat caspase-3 gene promoter. J. Biol. Chem. 277, 8273-8278.
40. MACIAN, F., GARCIA-COZAR, F., IM, S.H., HORTON, H.F., BYRNE, M.C., and RAO, A. (2002). Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731.
41. MACLEOD, D., CHARLTON, J., MULLINS, J., and BIRD, A.P. (1994). Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8, 2282-2292.
42. MEIER, P., FINCH, A., and EVAN, G. (2000). Apoptosis in development. Nature 407, 796-801.
43. MIOSSEC, C., DUTILLEUL, V., FASSY, F., and DIU-HERCEND, A. (1997). Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272, 13459-13462.
44. MULLER, H., BRACKEN, A.P., VERNELL, R., MORONI, M.C., CHRISTIANS, F., GRASSILLI, E., PROSPERINI, E., VIGO, E., OLINER, J.D., and HELIN, K. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267-285.
45. NAHLE, Z., POLAKOFF, J., DAVULURI, R.V., MCCURRACH, M.E., JACOBSON, M.D., NARITA, M., ZHANG, M.Q., LAZEBNIK, Y., BAR-SAGI, D., and LOWE, S.W. (2002). Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4, 859-864.
46. NAKAGAWA, T., ZHU, H., MORISHIMA, N., LI, E., XU, J., YANKNER, B.A., and YUAN, J. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
47. NI, B., WU, X., SU, Y., STEPHENSON, D., SMALSTIG, E.B., CLEMENS, J., and PAUL, S.M. (1998). Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons. J. Cereb. Blood Flow Metab. 18, 248-256.
48. O'NEILL, R.M., HASSAN, J., and REEN, D.J. (2003). IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death. J. Immunol. 170, 4524-4531.
49. OSSINA, N.K., CANNAS, A., POWERS, V.C., FITZPATRICK, P.A., KNIGHT, J.D., GILBERT, J.R., SHEKHTMAN, E.M., TOMEI, L.D., UMANSKY, S.R., and KIEFER, M.C. (1997). Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272, 16351-16357.
50. RAO, A., LUO, C., and HOGAN, P.G. (1997). Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 15, 707-747.
51. REFAELI, Y., VAN PARIJS, L., ALEXANDER, S.I., and ABBAS, A.K. (2002). Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196, 999-1005.
52. RIKHOF, B., CORN, P.G., and EL DEIRY, W.S. (2003). Caspase 10 levels are increased following DNA damage in a p53-dependent manner. Cancer Biol. Ther. 2, 707-712.
53. RUSSELL, J.H., and WANG, R. (1993). Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23, 2379-2382.
54. RUSSELL, J.H., RUSH, B., WEAVER, C., and WANG, R. (1993). Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90, 4409-4413.
55. SABBAGH, L., KAECH, S.M., BOURBONNIERE, M., WOO, M., COHEN, L.Y., HADDAD, E.K., LABRECQUE, N., AHMED, R., and SEKALY, R.P. (2004). The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis. J. Immunol. 173, 5425-5433.
56. SABBAGH, L., BOURBONNIERE, M., SEKALY, R.P., and COHEN, L.Y. (2005). Selective up-regulation of caspase-3 gene expression following TCR engagement. Mol. Immunol. 42, 1345-1354.
57. SALEH, M., VAILLANCOURT, J.P., GRAHAM, R.K., HUYCK, M., SRINIVASULA, S.M., ALNEMRI, E.S., STEINBERG, M.H., NOLAN, V., BALDWIN, C.T., HOTCHKISS, R.S., et al. (2004). Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75-79.
58. SALMENA, L., LEMMERS, B., HAKEM, A., MATYSIAK-ZABLOCKI, E., MURAKAMI, K., AU, P.Y., BERRY, D.M., TAMBLYN, L., SHEHABELDIN, A., MIGON, E., et al. (2003). Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17, 883-895.
59. TAKITA, J., YANG, H.W., CHEN, Y.Y., HANADA, R., YAMAMOTO, K., TEITZ, T., KIDD, V., and HAYASHI, Y. (2001). Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20, 4424-4432.
60. TEITZ, T., WEI, T., VALENTINE, M.B., VANIN, E.F., GRENET, J., VALENTINE, V.A., BEHM, F.G., LOOK, A.T., LAHTI, J.M., and KIDD, V.J. (2000). Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6, 529-535.
61. TRIEZENBERG, S.J. (1992). Primer extension assay. In Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Strahl, eds. (John Wiley and Sons, Inc., Hoboken, NJ), Vol. 1, pp. 4.8.1-4.8.5.
62. TRIMARCHI, J.M., and LEES, J.A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3, 11-20.
63. VARFOLOMEEV, E.E., SCHUCHMANN, M., LURIA, V., CHIANNILKULCHAI, N., BECKMANN, J.S., METT, I.L., REBRIKOV, D., BRODIANSKI, V.M., KEMPER, O.C., KOLLET, O., et al. (1998). Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors. Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276.
64. VENDRAME, F., SANTANGELO, C., MISASI, R., DIONISI, S., GIZZI, C., REALACCI, M., GRASSETTI, D., DI MARIO, U., and DOTTA, F. (2005). Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus. Eur. J. Endocrinol. 152, 119-125.
65. WILHELM, S., WAGNER, H., and HACKER, G. (1998). Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur. J. Immunol. 28, 891-900.
66. WOO, M., HAKEM, R., SOENGAS, M.S., DUNCAN, G.S., SHAHINIAN, A., KAGI, D., HAKEM, A., MCCURRACH, M., KHOO, W., KAUFMAN, S.A., et al. (1998). Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819.
67. WU, C. (1997). Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272, 28171-28174.
68. YEH, W.C., POMPA, J.L., MCCURRACH, M.E., SHU, H.B., ELIA, A.J., SHAHINIAN, A., NG, M., WAKEHAM, A., KHOO, W., MITCHELL, K., et al. (1998). FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958.
69. YOSHIDA, H., KONG, Y.Y., YOSHIDA, R., ELIA, A.J., HAKEM, A., HAKEM, R., PENNINGER, J.M., and MAK, T.W. (1998). Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94, 739-750.